Public health strategies should prioritize immunizing those at the highest risk for severe disease, such as the elderly and those with significant comorbidities, rather than a broad, one-size-fits-all

“the science and the data said people primarily over 65 are people with significant comorbidities were at risk for severe disease those are the individuals that should have been immunized first and we should have put our science behind our immunization schedule and protected those most at risk”